The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy
Abstract
Sickle cell disease (SCD) is caused by a single point mutation in the human betaA globin gene that results in the formation of an abnormal hemoglobin [HbS (alpha2betaS2)]. We designed a betaA globin gene variant that prevents HbS polymerization and introduced it into a lentiviral vector we optimized for transfer to hematopoietic stem cells and gene expression in the adult red blood cell lineage. Long-term expression (up to 10 months) was achieved, without preselection, in all transplanted mice with erythroid-specific accumulation of the antisickling protein in up to 52% of total hemoglobin and 99% of circulating red blood cells. In two mouse SCD models, Berkeley and SAD, inhibition of red blood cell dehydration and sickling was achieved with correction of hematological parameters, splenomegaly, and prevention of the characteristic urine concentration defect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Replacing b 87 threonine (T) with Q (HbA T87Q ) and incorporating this gene into a lentiviral vector that was transferred into hematopoietic stem cells corrected the main features of sickle cell disease in transgenic mice.115”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [115]
In the citing paper
“After establishing that β-globin lentiviral vectors had successfully corrected models of β-thalassemia and sickle cell disease in mice, 17,18 we initiated a human clinical study of ex vivo gene therapy for the β-hemoglobinopathies”
From Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia (2018) · cites this paper as [18]
Citations
Cites
Szer, J. (1999) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,353
Position-independent, high-level expression of the human β-globin gene in transgenic mice
Grosveld, F., van Assendelft, G. B., Greaves, D. R., & Kollias, G. (1987) · Cell · doi:10.1016/0092-8674(87)90584-8 · Cited by 1,909
INGRAM, V. M. (1957) · Nature · doi:10.1038/180326a0 · Cited by 978
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., & Charneau, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80828-4 · Cited by 833
The Molecular Basis of Blood Diseases.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-6-950_3 · Cited by 632
The "beta-like-globin" gene domain in human erythroid cells.
Tuan, D., Solomon, W., Li, Q., & London, I. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6384 · Cited by 601
Self-citationMay, C., Rivella, S., Callegari, J., Heller, G., Gaensler, K. M. L., Luzzatto, L., & Sadelain, M. (2000) · Nature · doi:10.1038/35017565 · Cited by 567
Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
Pászty, C., Brion, C. M., Manci, E., Witkowska, H. E., Stevens, M. E., Mohandas, N., & Rubin, E. M. (1997) · Science · doi:10.1126/science.278.5339.876 · Cited by 467
Knockout-Transgenic Mouse Model of Sickle Cell Disease
Ryan, T. M., Ciavatta, D. J., & Townes, T. M. (1997) · Science · doi:10.1126/science.278.5339.873 · Cited by 300
Bender, M. A., Bulger, M., Close, J., & Groudine, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80433-5 · Cited by 224
Research works printed but not linked: 3
- R. L. Nagel M. H. Steinberg in Disorders of Hemoglobin: Genetics Pathophysiology and Clinical Management M. H. Steinberg B. G. Forget D. R. Higgs R. L. Nagel Eds. (Cambridge Univ. Press Cambridge 2001) pp. 711–756.
- Supplementary Web material is available on Science Online at www.sciencemag.org/cgi/content/full/294/5550/2368/DC1.
- We thank A. Bank and S. Goff for HIV components and critical review of the manuscript; R. M. Bookchin and Z. Etzion for Bayer-Technicon red cell analysis; S. Pack P. Rouyer-Fessard and S. Suzuka for expert technical assistance; R. Nancel for art work; Supported by NIH grant HL554352 (M.E.F. I.M.L. C.E. R.K.H R.L.N. P.L.) INSERM (Y.B. P.L.) and Association Française contre la Myopathie (Y.B. P.L.).
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.10 · Cited by 1,501
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., Westerman, K., et al. (2010) · Nature · doi:10.1038/nature09328 · Cited by 1,276
Self-citationStuart, M. J., & Nagel, R. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17192-4 · Cited by 819
Self-citation
Metadata
- Authors
- Pawliuk, R., Westerman, K. A., Fabry, M. E., Payen, E., Tighe, R., Bouhassira, E. E., Acharya, S. A., Ellis, J., London, I. M., Eaves, C. J., Humphries, R. K., Beuzard, Y., Nagel, R. L., & Leboulch, P.
- Affiliations
- Harvard–MIT Division of Health Sciences and Technology (US)
- Albert Einstein College of Medicine (US)
- Inserm (FR)
- Hospital for Sick Children (CA)
- University of British Columbia (CA)
- Brigham and Women's Hospital (US)
- Corresponding author
- Leboulch, Philippe
- ORCID
- Venue
- Science
- Published
- 2001-12-14
- Volume
- 294
- Issue
- 5550
- Pages
- 2368-2371
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2111444354
- Semantic Scholar
- 8478aea66daadff3ca4dac81dd340b3bafdacdc1
- Cited by
- 579
- References
- 33
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 13 · 2023: 22 · 2022: 13 · 2021: 15 · 2020: 18 · 2019: 13 · 2018: 31 · 2017: 19 · 2016: 23 · 2015: 14 · 2014: 17 · 2013: 18 · 2012: 22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL554352)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- sickle cell disease, beta-globin gene, lentiviral vectors, hematopoietic stem cell gene therapy, transgenic mouse model, erythroid-specific gene expression, splenomegaly, red blood cell dehydration
- MeSH terms
- Anemia, Sickle Cell, Animals, Disease Models, Animal, Erythrocytes, Genetic Vectors, Globins, Hematopoietic Stem Cells, Hemoglobin, Sickle, Humans, Mice, Inbred C57BL, Mice, Transgenic, Oxyhemoglobins, RNA, Messenger, Thalassemia, Transduction, Genetic, Genetic Therapy, HIV-1, Gene Expression, Lentivirus, Hematopoietic Stem Cell Transplantation, Transgenes, Locus Control Region, Mice, beta-Globins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy. https://app.cochat.ai/papers/10.1126/science.1065806
- The paper
- Pawliuk, R., Westerman, K. A., Fabry, M. E., Payen, E., Tighe, R., Bouhassira, E. E., Acharya, S. A., Ellis, J., London, I. M., Eaves, C. J., Humphries, R. K., Beuzard, Y., Nagel, R. L., & Leboulch, P. (2001). Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy. Science. https://doi.org/10.1126/science.1065806
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.